|
1
|
Yang ZF, Ngai P, Ho DW, Yu WC, Ng MN, Lau
CK, Li ML, Tam KH, Lam CT, Poon RT and Fan ST: Identification of
local and circulating cancer stem cells in human liver cancer.
Hepatology. 47:919–928. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pardal R, Clarke MF and Morrison SJ:
Applying the principles of stem-cell biology to cancer. Nat Rev
Cancer. 3:895–902. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rossi DJ and Weissman IL: Pten,
tumorigenesis, and stem cell self-renewal. Cell. 125:229–231. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Widschwendter M, Fiegl H, Egle D,
Mueller-Holzner E, Spizzo G, Marth C, Weisenberger DJ, Campan M,
Young J, Jacobs I and Laird PW: Epigenetic stem cell signature in
cancer. Nat Genet. 39:157–158. 2007. View
Article : Google Scholar
|
|
5
|
Ben-Porath I, Thomson MW, Carey VJ, Ge R,
Bell GW, Regev A and Weinberg RA: An embryonic stem cell-like gene
expression signature in poorly differentiated aggressive human
tumors. Nat Genet. 40:499–507. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wong DJ, Liu H, Ridky TW, Cassarino D,
Segal E and Chang HY: Module map of stem cell genes guides creation
of epithelial cancer stem cells. Cell Stem Cell. 2:333–344. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takahashi K and Yamanaka S: Induction of
pluripotent stem cells from mouse embryonic and adult firoblast
cultures by defined factors. Cell. 126:663–676. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu J, Vodyanik MA, Smuga-Otto K,
Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA,
Ruotti V, Stewart R, Slukvin II and Thomson JA: Induced pluripotent
stem cell lines derived from human somatic cells. Science.
318:1917–1920. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rodini CO, Suzuki DE, Saba-Silva N,
Cappellano A, de Souza JE, Cavalheiro S, Toledo SR and Okamoto OK:
Expression analysis of stem cell-related genes reveal OCT4 as a
predictor of poor clinical outcome in medulloblastoma. J
Neurooncol. 106:71–79. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Saiki Y, Ishimaru S, Mimori K, Takatsuno
Y, Nagahara M, Ishii H, Yamada K and Mori M: Comprehensive analysis
of the clinical significance of inducing pluripotent
stemness-related gene expression in colorectal cancer cells. Ann
Surg Oncol. 16:2638–2644. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun HC, Zhang W, Qin LX, Zhang BH, Ye QH,
Wang L, Ren N, Zhuang PY, Zhu XD, Fan J and Tang ZY: Positive serum
hepatitis B e antigen is associated with higher risk of early
recurrence and poorer survival in patients after curative resection
of hepatitis B-related hepatocellular carcinoma. J Hepatol.
47:684–690. 2007. View Article : Google Scholar
|
|
12
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang XR, Xu Y, Shi GM, Fan J, Zhou J, Ji
Y, Sun HC, Qiu SJ, Yu B, Gao Q, He YZ, et al: Cytokeratin 10 and
cytokeratin 19: predictive markers for poor prognosis in
hepatocellular carcinoma patients after curative resection. Clin
Cancer Res. 14:3850–3859. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun HC, Zhuang PY, Qin LX, Ye QH, Wang L,
Ren N, Zhang JB, Qian YB, Lu L, Fan J and Tang ZY: Incidence and
prognostic values of lymph node metastasis in operable
hepatocellular carcinoma and evaluation of routine complete
lymphadenectomy. J Surg Oncol. 96:37–45. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Raeside DE: Monte Carlo principles and
applications. Phys Med Biol. 21:181–197. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Evans PM and Liu C: Roles of Krüpel-like
factor 4 in normal homeostasis, cancer and stem cells. Acta Biochim
Biophys Sin. 40:554–564. 2008.
|
|
17
|
Zhou Y, Hofstetter WL, He Y, Hu W, Pataer
A, Wang L, Wang J, Zhou Y, Yu L, Fang B and Swisher SG: KLF4
inhibition of lung cancer cell invasion by suppression of SPARC
expression. Cancer Biol Ther. 9:507–513. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zammarchi F, Morelli M, Menicagli M, Di
Cristofano C, Zavaglia K, Paolucci A, Campani D, Aretini P, Boggi
U, Mosca F, Cavazzana A, et al: KLF4 is a novel candidate tumor
suppressor gene in pancreatic ductal carcinoma. Am J Pathol.
178:361–372. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pandya AY, Talley LI, Frost AR, Fitzgerald
TJ, Trivedi V, Chakravarthy M, Chhieng DC, Grizzle WE, Engler JA,
Krontiras H, Bland KI, LoBuglio AF, Lobo-Ruppert SM and Ruppert JM:
Nuclear localization of KLF4 is associated with an aggressive
phenotype in early-stage breast cancer. Clin Cancer Res.
10:2709–2719. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Foster KW, Liu Z, Nail CD, Li X,
Fitzgerald TJ, Bailey SK, Frost AR, Louro ID, Townes TM, Paterson
AJ, Kudlow JE, et al: Induction of KLF4 in basal keratinocytes
blocks the proliferation-differentiation switch and initiates
squamous epithelial dysplasia. Oncogene. 24:1491–1500. 2005.
View Article : Google Scholar
|
|
21
|
Chen YJ, Wu CY, Chang CC, Ma CJ, Li MC and
Chen CM: Nuclear Krüppel-like factor 4 expression is associated
with human skin squamous cell carcinoma progression and metastasis.
Cancer Biol Ther. 7:777–782. 2008.
|
|
22
|
Fong H, Hohenstein KA and Donovan PJ:
Regulation of self-renewal and pluripotency by Sox2 in human
embryonic stem cells. Stem Cells. 26:1931–1938. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hussenet T, Dali S, Exinger J, Monga B,
Jost B, Dembelé D, Martinet N, Thibault C, Huelsken J, Brambilla E
and du Manoir S: Sox2 is an oncogene activated by recurrent 3q26.3
amplifications in human lung squamous cell carcinomas. PLoS One.
5:e89602010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen Y, Shi L, Zhang L, Li R, Liang J, Yu
W, Sun L, Yang X, Wang Y, Zhang Y and Shang Y: The molecular
mechanism governing the oncogenic potential of Sox2 in breast
cancer. J Biol Chem. 283:17969–17978. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gangemi RM, Griffero F, Marubbi D, Perera
M, Capra MC, Malatesta P, Ravetti GL, Zona GL, Daga A and Corte G:
Sox2 silencing in glioblastoma tumor-initiating cells causes stop
of proliferation and loss of tumorigenicity. Stem Cells. 27:40–48.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sanada Y, Yoshida K, Ohara M, Oeda M,
Konishi K and Tsutani Y: Histopathologic evaluation of stepwise
progression of pancreatic carcinoma with immunohistochemical
analysis of gastric epithelial transcription factor Sox2:
comparison of expression patterns between invasive components and
cancerous or nonneoplastic intraductal components. Pancreas.
32:164–170. 2006.
|
|
27
|
Nichols J, Zevnik B, Anastassiadis K, Niwa
H, Klewe-Nebenius D, Chambers I, Schöler H and Smith A: Formation
of pluripotent stem cells in the mammalian embryo depends on the
POU transcription factor Oct4. Cell. 95:379–391. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chambers I, Colby D, Robertson M, Nichols
J, Lee S, Tweedie S and Smith A: Functional expression cloning of
Nanog, a pluripotency sustaining factor in embryonic stem cells.
Cell. 113:643–655. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chang CC: Recent translational research:
stem cells as the roots of breast cancer. Breast Cancer Res.
8:1032006. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Du Z, Jia D, Liu S, Wang F, Li G, Zhang Y,
Cao X, Ling EA and Hao A: Oct4 is expressed in human gliomas and
promotes colony formation in glioma cells. Glia. 57:724–733. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou X, Zhou YP, Huang GR, Gong BL, Yang
B, Zhang DX, Hu P and Xu SR: Expression of the stem cell marker,
Nanog, in human endometrial adenocarcinoma. Int J Gynecol Pathol.
30:262–270. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin T, Ding YQ and Li JM: Overexpression
of Nanog protein is associated with poor prognosis in gastric
adenocarcinoma. Med Oncol. 29:878–885. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Meng HM, Zheng P, Wang XY, Liu C, Sui HM,
Wu SJ, Zhou J, Ding YQ and Li JM: Overexpression of Nanog predicts
tumor progression and poor prognosis in colorectal cancer. Cancer
Biol Ther. 9:295–302. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wen J, Park JY, Park KH, Chung HW, Bang S,
Park SW and Song SY: Oct4 and Nanog expression is associated with
early stages of pancreatic carcinogenesis. Pancreas. 39:622–626.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ,
Tsai TH, Chou SH, Chien CS, Ku HH and Lo JF: Positive correlations
of Oct-4 and Nanog in oral cancer stem-like cells and high-grade
oral squamous cell carcinoma. Clin Cancer Res. 14:4085–4095. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Grandori C, Cowley SM, James LP and
Eisenman RN: The Myc/Max/Mad network and the transcriptional
control of cell behavior. Annu Rev Cell Dev Biol. 16:653–699. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ma L, Young J, Prabhala H, Pan E, Mestdagh
P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S,
Westermann F, et al: miR-9, a MYC/MYCN-activated microRNA,
regulates E-cadherin and cancer metastasis. Nat Cell Biol.
12:247–256. 2010.PubMed/NCBI
|
|
38
|
Rapp UR, Korn C, Ceteci F, Karreman C,
Luetkenhaus K, Serafin V, Zanucco E, Castro I and Potapenko T: MYC
is a metastasis gene for non-small-cell lung cancer. PLoS One.
4:e60292009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dominguez-Sola D, Ying CY, Grandori C,
Ruggiero L, Chen B, Li M, Galloway DA, Gu W, Gautier J and
Dalla-Favera R: Non-transcriptional control of DNA replication by
c-Myc. Nature. 448:445–451. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Soucek L, Lawlor ER, Soto D, Shchors K,
Swigart LB and Evan GI: Mast cells are required for angiogenesis
and macroscopic expansion of Myc-induced pancreatic islet tumors.
Nat Med. 13:1211–1218. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dangi-Garimella S, Yun J, Eves EM, Newman
M, Erkeland SJ, Hammond SM, Minn AJ and Rosner MR: Raf kinase
inhibitory protein suppresses a metastasis signalling cascade
involving LIN28 and let-7. EMBO J. 28:347–358. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hamano R, Miyata H, Yamasaki M, Sugimura
K, Tanaka K, Kurokawa Y, Nakajima K, Takiguchi S, Fujiwara Y, Mori
M and Doki Y: High expression of Lin28 is associated with tumour
aggressiveness and poor prognosis of patients in oesophagus cancer.
Br J Cancer. 106:1415–1423. 2012. View Article : Google Scholar : PubMed/NCBI
|
